ConductScience.org, home

Paper30730552

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.

Nicolosi P and 8 others. JAMA Oncol, 2019. Cited by 302 papers, by iCite.

Cite this record

ConductScience Library. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. Papers, record 30730552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30730552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
PubMed
Journal
JAMA Oncol
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
302
iCite
Relative citation ratio, by iCite
11.1
iCite
Revised in PubMed
2024-07-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nicolosi PPiper
2Ledet EElisa
3Yang SShan
4Michalski SScott
5Freschi BBrandy
6O'Leary EErin
7Esplin EDEdward D
8Nussbaum RLRobert L
9Sartor OOliver

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic Predisposition to DiseaseMajor topic
Germ-Line MutationMajor topic
Prostatic NeoplasmsMajor topic
Aged
Cross-Sectional Studies
Genetic Testing
Guidelines as Topic
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124484606Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.Eur Urol2014https://conductscience.org/library/papers/24484606PubMed
224556621Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.Br J Cancer2014https://conductscience.org/library/papers/24556621PubMed
329236593Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.J Clin Oncol2018https://conductscience.org/library/papers/29236593PubMed
425394175A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.Genet Med2015https://conductscience.org/library/papers/25394175PubMed
529512888The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine.Am J Med Genet C Semin Med Genet2018https://conductscience.org/library/papers/29512888PubMed
628608931The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.Cancer2017https://conductscience.org/library/papers/28608931PubMed
727581128A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital.Breast Cancer Res Treat2016https://conductscience.org/library/papers/27581128PubMed
827433846Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.N Engl J Med2016https://conductscience.org/library/papers/27433846PubMed
928767289Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.J Clin Oncol2017https://conductscience.org/library/papers/28767289PubMed
1026000489Integrative clinical genomics of advanced prostate cancer.Cell2015https://conductscience.org/library/papers/26000489PubMed
1126207792A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.J Mol Diagn2015https://conductscience.org/library/papers/26207792PubMed
1223569316Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.J Clin Oncol2013https://conductscience.org/library/papers/23569316PubMed
1327989354Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.Eur Urol2017https://conductscience.org/library/papers/27989354PubMed
1428492532Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.Genet Med2017https://conductscience.org/library/papers/28492532PubMed
1528448241Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.J Clin Oncol2017https://conductscience.org/library/papers/28448241PubMed
1625454609Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.Eur Urol2015https://conductscience.org/library/papers/25454609PubMed
1727242960Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.Front Oncol2016https://conductscience.org/library/papers/27242960PubMed

Download CSV of references

Cited by187

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 302 citations.

PMIDTitleJournalYearIn PapersSource
42886888Plasma-Derived Genomic Instability Status and Rucaparib Outcomes in Metastatic Castration-Resistant Prostate Cancer: TRITON2.JCO Precis Oncol2026https://conductscience.org/library/papers/42886888PubMed
42842178Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan.Int J Clin Oncol2026https://conductscience.org/library/papers/42842178PubMed
42650149Population-Specific Genetic Markers of Prostate Cancer Risk in Kazakh Men: Association Analysis of 102 SNPs and Risk Prediction Modeling.Genes (Basel)2026https://conductscience.org/library/papers/42650149PubMed
42578161Germline HOXB13 G84E Variant in a Patient with Gastric and Prostate Cancer: A Case Report and Literature Review.Case Rep Oncol2026https://conductscience.org/library/papers/42578161PubMed
42565081Clinical Impact of Germline Pathogenic Variants in High-risk Prostate Cancer Treated with Radiotherapy.Eur Urol Open Sci2026https://conductscience.org/library/papers/42565081PubMed
42507335SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026).Clin Transl Oncol2026https://conductscience.org/library/papers/42507335PubMed
42502690Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study.Genet Med Open2026https://conductscience.org/library/papers/42502690PubMed
42488705Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection.MedComm (2020)2026https://conductscience.org/library/papers/42488705PubMed
42449576Implementation of Genetic Testing in Prostate Cancer: A Real-World Survey of Outpatient Urologists in Germany (PRO-GEN).Cancers (Basel)2026https://conductscience.org/library/papers/42449576PubMed
42438725The distinct molecular profile of metastatic prostate cancer in the mixed Brazilian population.Genet Med Open2026https://conductscience.org/library/papers/42438725PubMed
42415575Understanding the utilization of genetic counseling and testing among patients with prostate cancer.Can J Urol2026https://conductscience.org/library/papers/42415575PubMed
42232598Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas.Oncol Res2026https://conductscience.org/library/papers/42232598PubMed
42007214Exploring the genetic overlap between obstructive sleep apnea and prostate cancer.J Natl Cancer Cent2026https://conductscience.org/library/papers/42007214PubMed
42001130Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.Genome Med2026https://conductscience.org/library/papers/42001130PubMed
41623173Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine.J Clin Invest2026https://conductscience.org/library/papers/41623173PubMed
41579216Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Fam Cancer2026https://conductscience.org/library/papers/41579216PubMed
41561489Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.Eur Urol Open Sci2026https://conductscience.org/library/papers/41561489PubMed
41541272Predictive Genetic Testing in the Cancer Management and Prevention.J Cancer Sci Clin Ther2025https://conductscience.org/library/papers/41541272PubMed
41440226Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications.Curr Oncol2025https://conductscience.org/library/papers/41440226PubMed
41353608Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns.Prostate2026https://conductscience.org/library/papers/41353608PubMed

See all 187 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
HOXB1310481PubTator's text mininghttps://conductscience.org/library/genes/10481NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30730552

GET https://conductscience.org/api/papers/v1/30730552/cited_by?page=2